G. Marchesini

Publications263
h-index55
Citations16,889
Highly Influential Citations555
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • Z. Younossi
  • 1,027 Publications, 48,015 Citations
  • E. Bugianesi
  • 247 Publications, 20,115 Citations
  • T. Wadden
  • 532 Publications, 44,522 Citations
  • A. Sanyal
  • 837 Publications, 53,102 Citations
  • Publications
  • Influence
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
Nonalcoholic fatty liver disease (NAFLD) has been associated with the insulin‐resistance syndrome, at present defined as the metabolic syndrome, whose limits were recently set. We assessed the… Expand
  • 2,278
  • 80
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
Insulin sensitivity (euglycemic clamp, insulin infusion rate: 40 mU. m(-2). min(-1)) was studied in 30 subjects with biopsy-proven nonalcoholic fatty liver disease (NAFLD), normal glucose tolerance,… Expand
  • 2,151
  • 56
Association of nonalcoholic fatty liver disease with insulin resistance.
BACKGROUND AND PURPOSE Nonalcoholic fatty liver disease is frequently associated with type 2 diabetes mellitus, obesity, and dyslipidemia, but some patients have normal glucose tolerance or normal… Expand
  • 1,328
  • 41
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.
BACKGROUND & AIMS Nonalcoholic steatohepatitis (NASH) may progress to cirrhosis; whether NASH plays also a role in the development of hepatocellular carcinoma (HCC) is unknown. METHODS Among 641… Expand
  • 903
  • 22
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.
The conventional paradigm of nonalcoholic fatty liver disease representing the "hepatic manifestation of the metabolic syndrome" is outdated. We identified and summarized longitudinal studies that,… Expand
  • 363
  • 20
Factors associated with poor health-related quality of life of patients with cirrhosis.
BACKGROUND & AIMS Increasing interest is being given to health-related quality of life in chronic diseases. In cirrhosis, both physical functioning and mental well-being may be altered, but no study… Expand
  • 398
  • 19
Compulsive exercise to control shape or weight in eating disorders: prevalence, associated features, and treatment outcome.
OBJECTIVE The study was aimed at assessing the prevalence of compulsive exercising to control shape and weight in eating disorders (EDs) and its relationship with treatment outcome. METHOD… Expand
  • 202
  • 19
Weight loss expectations in obese patients and treatment attrition: an observational multicenter study.
OBJECTIVE To investigate the influence of weight loss expectations (expected 1-year BMI loss, dream and maximum acceptable BMI) on attrition in obese patients seeking treatment. RESEARCH METHODS… Expand
  • 258
  • 12
Obesity-associated liver disease.
CONTEXT In the last few years, several data have accumulated suggesting that obesity may be associated with liver disease and disease progression. Accordingly, the worldwide epidemic of obesity is… Expand
  • 231
  • 11
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.
Plasma levels of adiponectin are decreased in patients with nonalcoholic fatty liver disease (NAFLD), but the relationship among plasma adiponectin, insulin sensitivity, and histological features is… Expand
  • 359
  • 10